Picture of Genus logo

GNS Genus Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual income statement for Genus, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

R2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue551574593690669
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses509527544649662
Operating Profit42.447.749.440.56.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes46.355.848.439.45.5
Provision for Income Taxes
Net Income After Taxes35.746.836.731.82.4
Minority Interest
Net Income Before Extraordinary Items
Net Income35.347.340.933.37.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income35.347.340.933.37.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.6370.90.7110.7540.446
Dividends per Share